)
MapLight Therapeutics (MPLT) investor relations material
MapLight Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 23, 2026, to be held virtually for stockholders of record as of April 27, 2026.
Meeting materials, including the proxy statement and annual report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class I Director nominees to serve until the 2029 annual meeting: Martin Babler, Troy Cox, and George Pavlov.
Ratification of RSM US LLP as the independent registered public accounting firm for the year ending December 31, 2026.
Provision to conduct any other business properly brought before the meeting or its adjournment.
Board of directors and corporate governance
Board recommends voting FOR each director nominee and FOR the ratification of the auditor.
- Director elections, auditor ratification, and strong governance highlight this year's proxy.MPLT
Proxy filing29 Apr 2026 - Novel CNS therapies in Phase 2 trials show promise for schizophrenia, ADP, and ASD.MPLT
Corporate presentation26 Mar 2026 - Key Phase 2 trials advance as net loss widens; cash reserves expected to last through 2027.MPLT
Q4 202526 Mar 2026 - Advancing a robust CNS pipeline with differentiated therapies and strong financial runway.MPLT
Corporate Presentation9 Jan 2026 - Advancing a differentiated M₁/M4 agonist for CNS disorders with strong safety and financials.MPLT
Corporate Presentation4 Dec 2025 - Net loss rose to $81.6M as R&D spending increased; IPO proceeds extend runway through 2027.MPLT
Q3 20254 Dec 2025 - IPO funds will advance CNS drug pipeline, but further capital and regulatory success are needed.MPLT
Registration Filing31 Oct 2025 - IPO raises $234.8M to fund CNS drug pipeline, but ongoing losses and risks remain.MPLT
Registration Filing31 Oct 2025
Next MapLight Therapeutics earnings date
Next MapLight Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)